Colorectal Tumor Vascularity: Quantitative Assessment with Multidetector CT-Do Tumor Perfusion Measurements Reflect Angiogenesis?

被引:118
作者
Goh, Vicky [2 ]
Halligan, Steve [1 ]
Daley, Frances [3 ]
Wellsted, David M. [4 ]
Guenther, Thomas [5 ]
Bartram, Clive I. [6 ]
机构
[1] Univ Coll Hosp, Dept Acad Radiol, London NW1 2BU, England
[2] Mt Vernon Hosp, Paul Strickland Scanner Ctr, Northwood HA6 2RN, Middx, England
[3] Mt Vernon Hosp, Gray Canc Inst, Northwood HA6 2RN, Middx, England
[4] Univ Hertfordshire, Hlth Res & Dev Support Unit, Hatfield AL10 9AB, Herts, England
[5] St Marks Hosp, Acad Dept Histopathol, Harrow, Middx, England
[6] St Marks Hosp, Intestinal Imaging Ctr, Harrow, Middx, England
关键词
D O I
10.1148/radiol.2492071365
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To establish the relationships between quantitative perfusion computed tomography (CT) parameters-specifically, primary tumor blood flow, blood volume, transit time, and permeability surface-area product-and immunohistologic markers of angiogenesis in colorectal cancer. Materials and Methods: After institutional review board approval and informed patient consent were obtained for this prospective study, 23 patients (11 men, 12 women; mean age, 68.4 years; age range, 34.8 -87.1 years) with colorectal adenocarcinoma underwent a 65-second perfusion CT examination, and tumor blood flow, blood volume, mean transit time, and permeability surface-area product were determined. After surgery, resected specimens were sectioned and stained immunohistochemically to identify CD34 for quantification of microvessel density (MVD), to identify smooth muscle actin for assessment of pericyte coverage index, to identify vascular endothelial growth factor (VEGF), and to identify glucose transporter protein (GLUT-1). Perfusion CT measurements were correlated with MVD, pericyte coverage index, VEGF expression, and GLUT-1 expression by using Pearson or Spearman rank correlation analysis, with significance assigned at the 5% level. Results: Mean blood flow, blood volume, transit time, and permeability surface-area product values were 72.1 mL/min/100 g of tissue +/- 28.4 (standard deviation), 6.2 mL/100 g of tissue +/- 1.4, 9.3 seconds +/- 3.9, and 13.9 mL/min/100 g of tissue +/- 3.2, respectively. Blood volume (r = 0.59, P = .002) and permeability surface-area product (r = 0.46, P = .03) correlated positively with MVD, but blood flow (r = 0.27, P = .22) and transit time (r = -0.18, P = .44) did not. There were no significant associations between any perfusion CT parameter and pericyte coverage index (r <= 0.36, P > .05), VEGF score (rho <= 0.30, P >= .15), or GLUT-1 score (rho < 0.21, P >= .33). Conclusion: Tumor permeability surface-area product and blood volume correlate positively with MVD and may reflect the microvascularity of colorectal tumors. (C) RSNA, 2008
引用
收藏
页码:510 / 517
页数:8
相关论文
共 44 条
  • [1] Airley R, 2001, CLIN CANCER RES, V7, P928
  • [2] K-RAS GENE MUTATION RELATED TO HISTOLOGICAL ATYPIAS IN HUMAN COLORECTAL ADENOMAS
    AJIKI, T
    FUJIMORI, T
    IKEHARA, H
    SAITOH, Y
    MAEDA, S
    [J]. BIOTECHNIC & HISTOCHEMISTRY, 1995, 70 (02) : 90 - 94
  • [3] Dynamic contrast-enhanced magnetic resonance imaging is a poor measure of rectal cancer angiogenesis
    Atkin, G.
    Taylor, N. J.
    Daley, F. M.
    Stirling, J. J.
    Richman, P.
    Glynne-Jones, R.
    d'Arcy, J. A.
    Collins, D. J.
    Padhani, A. R.
    [J]. BRITISH JOURNAL OF SURGERY, 2006, 93 (08) : 992 - 1000
  • [4] TUMOR ANGIOGENESIS AS A PROGNOSTIC ASSAY FOR INVASIVE DUCTAL BREAST-CARCINOMA
    AXELSSON, K
    LJUNG, BME
    MOORE, DH
    THOR, AD
    CHEW, KL
    EDGERTON, SM
    SMITH, HS
    MAYALL, BH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (13) : 997 - 1008
  • [5] Fully automated microvessel counting and hot spot selection by image processing of whole tumour sections in invasive breast cancer
    Beliën, JAM
    Somi, S
    de Jong, JS
    van Diest, PJ
    Baak, JPA
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (03) : 184 - 192
  • [6] The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
    Beresford, M. J.
    Harris, A. L.
    Ah-See, M.
    Daley, F.
    Padhani, A. R.
    Makris, A.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (12) : 1683 - 1688
  • [7] Glucose transporter-1 (GLUT-1):: a potential marker of prognosis in rectal carcinoma?
    Cooper, R
    Sarioglu, S
    Sökmen, S
    Füzün, M
    Küpelioglu, A
    Valentine, H
    Görken, IB
    Airley, R
    West, C
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (05) : 870 - 876
  • [8] deJong JS, 1995, LAB INVEST, V73, P922
  • [9] Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature
    Des Guetz, G.
    Uzzan, B.
    Nicolas, P.
    Cucherat, M.
    Morere, J-F
    Benamouzig, R.
    Breau, J-L
    Perret, G-Y
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1823 - 1832
  • [10] Drevs J, 2002, CANCER RES, V62, P4015